On March 19, 2024, Harbin Wuzhou Animal Health Partners visited the Hisun Animal Health Vaccine Production Base for visits and exchanges.

At the first stop of the visit, Harbin Wuzhou Animal Health Partners learned about the development history and products of Hisun Animal Health Company. Showed strong interest in the company's dual ST program, Yunyuanqing [Porcine circovirus type 2, Mycoplasma hyopneumoniae dual inactivated vaccine (recombinant baculovirus DBN01 strain + DJ-166 strain)], etc., especially those that are about to be launched Yun Yuanqing also strengthened the guests' prospects for future cooperation projects.

Vaccine production director Wang Libin accompanied the visit to the inactivated vaccine workshop and explained the vaccine production process and quality control system. Harbin Wuzhou partners experienced the advanced production equipment and first-class production environment of the vaccine production base up close. Through this visit, the guests intuitively felt the production strength of Hisun’s animal health vaccine, and they were more confident in opening up a new situation of win-win cooperation.

In the future, Hisun Animal Health will base on its own advantages, work with more partners for mutual benefit, aggregate superior resources, continuously empower customers, and help customers develop their determination. Adhering to the corporate mission of "continuously providing health solutions for farm animals and companion animals", we realize the two-wheel drive of chemicals and vaccines to provide better products and better services for the animal health industry.